Company / Operating Cash Flow
Guardant Health, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$184.8M
FY2025
5-year range
-$325.0M / -$184.8M
FY2021-FY2025
Trend
+23.0%
vs FY2024
Sector context
#153 of 158
Health Care
What the data says
Among 158 Health Care companies, Guardant Health, Inc. is in the bottom 3% for operating cash flow. Operating Cash Flow has fluctuated over the past 10 years, ranging from -$325M in FY2023 to -$37M in FY2016.
Based on SEC 10-K filings.
-$185M in FY2025.
Improved from -$325M to -$185M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 158This company -$184.8M Sector average $1.0B
▼
-117.9% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow increased 23.0% year-over-year.
- Ranks #153 out of 158 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2016.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$184.8M | +23.0% |
| FY2024 | -$239.9M | +26.2% |
| FY2023 | -$325.0M | -5.0% |
| FY2022 | -$309.5M | -48.1% |
| FY2021 | -$209.0M | -101.1% |
| FY2020 | -$103.9M | -120.5% |
| FY2019 | -$47.1M | +34.7% |
| FY2018 | -$72.2M | +0.1% |
| FY2017 | -$72.2M | -96.8% |
| FY2016 | -$36.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026